[go: up one dir, main page]

MX2010009927A - Derivados de espiroindolinona. - Google Patents

Derivados de espiroindolinona.

Info

Publication number
MX2010009927A
MX2010009927A MX2010009927A MX2010009927A MX2010009927A MX 2010009927 A MX2010009927 A MX 2010009927A MX 2010009927 A MX2010009927 A MX 2010009927A MX 2010009927 A MX2010009927 A MX 2010009927A MX 2010009927 A MX2010009927 A MX 2010009927A
Authority
MX
Mexico
Prior art keywords
spiroindolinone derivatives
spiroindolinone
derivatives
compounds
medicaments
Prior art date
Application number
MX2010009927A
Other languages
English (en)
Inventor
Jin-Jun Liu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2010009927A publication Critical patent/MX2010009927A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención proporciona compuestos de la fórmula general en donde W, X, Y, R1, R2, R3, y R4 son como se describen aquí, procesos de fabricación de tales compuestos así como métodos de uso de los mismos, en particular su uso como medicamentos, más particularmente como agentes anticancerígenos.
MX2010009927A 2008-03-19 2009-03-09 Derivados de espiroindolinona. MX2010009927A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3779908P 2008-03-19 2008-03-19
PCT/EP2009/052737 WO2009115425A1 (en) 2008-03-19 2009-03-09 Spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
MX2010009927A true MX2010009927A (es) 2010-09-30

Family

ID=40595697

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010009927A MX2010009927A (es) 2008-03-19 2009-03-09 Derivados de espiroindolinona.

Country Status (13)

Country Link
US (1) US7723372B2 (es)
EP (1) EP2265583B1 (es)
JP (1) JP2011515353A (es)
KR (1) KR20100121521A (es)
CN (1) CN101977898A (es)
AT (1) ATE528290T1 (es)
AU (1) AU2009226866A1 (es)
BR (1) BRPI0909333A2 (es)
CA (1) CA2716979A1 (es)
ES (1) ES2373857T3 (es)
IL (1) IL208025A0 (es)
MX (1) MX2010009927A (es)
WO (1) WO2009115425A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010319595B2 (en) 2009-11-12 2015-09-17 The Regents Of The University Of Michigan Spiro-oxindole MDM2 antagonists
CA2817585A1 (en) 2010-11-12 2012-05-18 The Regents Of The University Of Michigan Spiro-oxindole mdm2 antagonists
HUE038714T2 (hu) 2011-03-10 2018-11-28 Daiichi Sankyo Co Ltd Dispiropirrolidin származék
CN102180828A (zh) * 2011-03-31 2011-09-14 四川大学 手性吲哚啉酮螺五环骨架化合物及不对称合成
CA2835422C (en) 2011-05-11 2016-10-11 The Regents Of The University Of Michigan Spiro-oxindole mdm2 antagonists
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
CN103172555B (zh) * 2012-12-07 2014-07-09 山东绿叶制药有限公司 升麻中分离的吲哚生物碱化合物、制备方法及其用途
ES2858151T3 (es) 2016-05-20 2021-09-29 Hoffmann La Roche Conjugados de PROTAC-anticuerpo y procedimientos de uso
EP3511334A1 (en) * 2018-01-16 2019-07-17 Adamed sp. z o.o. 1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114937A (en) * 1989-11-28 1992-05-19 Warner-Lambert Company Renin inhibiting nonpeptides
FR2740136B1 (fr) 1995-10-24 1998-01-09 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
WO2006091646A2 (en) * 2005-02-22 2006-08-31 The Regents Of The University Of Michigan Small molecule inhibitors of mdm2 and uses thereof
US7495007B2 (en) * 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
US7638548B2 (en) * 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20080188506A1 (en) 2007-02-07 2008-08-07 Qingjie Ding Spiroindolinone derivatives
US7553833B2 (en) 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives
US7834179B2 (en) 2007-05-23 2010-11-16 Hoffmann-La Roche Inc. Spiroindolinone derivatives

Also Published As

Publication number Publication date
EP2265583B1 (en) 2011-10-12
EP2265583A1 (en) 2010-12-29
JP2011515353A (ja) 2011-05-19
CN101977898A (zh) 2011-02-16
US7723372B2 (en) 2010-05-25
AU2009226866A1 (en) 2009-09-24
BRPI0909333A2 (pt) 2019-09-24
IL208025A0 (en) 2010-12-30
ATE528290T1 (de) 2011-10-15
WO2009115425A1 (en) 2009-09-24
CA2716979A1 (en) 2009-09-24
US20090239889A1 (en) 2009-09-24
ES2373857T3 (es) 2012-02-09
KR20100121521A (ko) 2010-11-17

Similar Documents

Publication Publication Date Title
MX2010009927A (es) Derivados de espiroindolinona.
MX2009004766A (es) Derivados de espiroindolinona.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
MY153921A (en) Aminopyrazole derivatives
IL197197A0 (en) Oxindole derivatives as anticancer agents
MY160424A (en) Substituted pyrrolidine-2-carboxyamides.
UA102858C2 (ru) Производные пиридино-пиридинонов, способ их получения и применения в терапии
TW200800999A (en) Novel compounds
MX2014014229A (es) Pirrolidina-2-carboxamidas sustituidas.
TW200801003A (en) Novel compounds
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
IL193620A0 (en) Spiroindolinone derivatives
TW200745084A (en) Novel compounds
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
IN2012DN02487A (es)
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
MX2015000362A (es) Benzo(b)-azepin-2-onas antiproliferativas.
TW200942524A (en) Novel aminomethyl benzene derivatives
NZ597483A (en) N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
MY183039A (en) Pyridin-2-yl derivatives as immunomodulating agents
MX2012007896A (es) Derivados de piridino-piridinonas arilsulfonamidas, su preparacion y su uso en terapeutica.
TW200940659A (en) Azopyridone disperse dyes, their preparation and use
TW200800969A (en) Compounds

Legal Events

Date Code Title Description
FG Grant or registration